Novo Nordisk’s diabetes drug Ozempic slashed the risk of kidney disease progression in trial

The results add to the growing evidence that the highly popular injection has broader health benefits for patients beyond treating Type 2 diabetes.

Previous post New CFPB rule caps banks’ credit card late fees at $8
Next post Labor unions end proxy fight at Starbucks after bargaining progress